Product
5-methoxy-N,N-dimethyltryptamine
1 clinical trial
3 indications
Indication
pharmacokineticsIndication
SafetyIndication
TolerabilityClinical trial
A Phase 1, First-in-human, Double-blind, Placebo-controlled, Randomized, Single- and Multiple-ascending-dose Study to Determine the Safety, Tolerability, and Pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) Administered by Intramuscular Injection in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-09-07